A Study of LY3323795 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 12, 2016

Primary Completion Date

July 21, 2017

Study Completion Date

July 21, 2017

Conditions

Healthy

Interventions

DRUG

LY3323795

Administered orally

DRUG

Itraconazole

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

California Clinical Trials Medical Group, Glendale

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT02989389 - A Study of LY3323795 in Healthy Participants | Biotech Hunter | Biotech Hunter